Literature DB >> 25817073

BRAF V600 point mutation is not present in relapsing meningioma.

Fabien Forest, Violaine Yvorel, François Vassal, Béatrice Trombert, Jean-Marc Dumollard, Christophe Nuti, Michel Péoc'h.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25817073     DOI： 10.5414/NP300836

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN： 0722-5091            Impact factor:   1.368


× No keyword cloud information.
  2 in total

1.  Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib.

Authors:  Aisulu Usubalieva; Christopher R Pierson; Christina A Kavran; Kristin Huntoon; Oleksandr N Kryvenko; Theodore G Mayer; Weiqiang Zhao; Jack Rock; Mario Ammirati; Vinay K Puduvalli; Norman L Lehman
Journal:  J Neuropathol Exp Neurol       Date:  2015-10       Impact factor: 3.685

2.  New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses.

Authors:  Aysha AlSahlawi; Rasha Aljelaify; Malak Abedalthagafi; Amna Magrashi; Mariam AlSaeed; Amal Almutairi; Fatimah Alqubaishi; Abdulellah Alturkistani; Abdullah AlObaid; Mohamed Abouelhoda; Latifa AlMubarak; Nada AlTassan
Journal:  Oncotarget       Date:  2019-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.